Maybe? I think originally was CoH trying to pull bisantrene out from under us way back in the day, you could speculate that when that didn't work they revised their strategy to combining datasets? I think we would never know though if that was the case unless you could get chatting to someone in the know over a beer. I usually rely on others in the forum more informed on biotechs and their inner workings but to me while definitely speculative I can't see a reason why not? Maybe it wasn't planned years ago but if CoH wanted to do anything with bisantrene now you would think that's how they would go about it
Ann: Letter to Shareholders, page-85
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |